INTRODUCTION
Livestock is very important in the agriculturally based, resource poor economies and social structures of subSaharan Africa. Endemic and periodically epidemic foot and mouth disease (FMD) has serious impact on food security (including crop production through its effect on draught animals), rural income generation and national economies by impairing livestock trade. Consequently, the poorest sectors of the community are most seriously affected. The progressive control of FMD is both a national priority and regional imperative (Khounsy et al., 2008) . FMD is the most contagious disease of mammals and can cause severe economic losses in susceptible cloven-hoofed animals. While the disease usually does not cause high level of mortality, it results in productivity losses and induces lameness and its attendant and other equipment and is mainly used in large laboratories which can afford to purchase and maintain this capability (Morrissy et al., 2008) .
Molecular Techniques
In the years since the advent of genetic diagnostic techniques nearly two decades ago, more than 50 different nucleic acid hybridization and various PCR technologies have been reported for the diagnosis of FMD (Reid et al., 2002) . Recently, real time PCR methods (Taq Man, molecular beacons, Primer-Probe Energy Transfer System) have been developed for FMD diagnosis and are now the mainstay for FMD genetic diagnosis (Reid et al., 2002; Oem et al., 2005; Wieslaw et al., 2010) . Evaluation of real time PCR methods with conventional diagnostics (Shaw et al., 2004; Ferris et al., 2006) concluded that PCR was generally more sensitive and rapid, and is ideal for samples which contain low concentrations of virus. By introducing nucleic acid extraction and p i p e t t i n g r o b o t i c s , t o g e t h e r w i t h multichannel real time PCR machines, diagnostic procedures have become rapid, robust and automated but may not be best suited to low technology settings. Another promising development for the developing country laboratories is the one-step, reverse transcription loop-mediated amplification (RT-LAMP) assay, which enables FMD virus to be detected in under 1 hour in a single tube without thermal cycling (Dukes et al., 2006; Jun-Jun et al., 2010 T h e F M D A C -E L I S A r e p l a c e d t h e complement fixation test for primary FMD diagnosis and serotype identification because of its increased specificity and sensitivity and because it is not affected by pro-or anti-complementary factors in the test sample (Ferris and Dawson 1988) . Standard reagents for the FMD AC-ELISA are produced at the World Reference Laboratory (WRL) for FMD, Pirbright, United Kingdom.
Sample quality is important as lesions older than 4-5 days have less antigens; however, samples unsuitable for virus isolation can be tested by ELISA. The ELISA allows high throughput testing of samples and is well suited to low technology settings. Higher throughput can be achieved with robotics inactivation and purification) may induce a false positive result in this test. In these cases, the history from the field, e.g. about p o t e n t i a l o u t b r e a k s / i n f e c t i o n , identification of vaccine and number of vaccinations received, is important for correct interpretation of the result.
The use of vaccine for the control of FMD has led to the development of a number of assays for the detection of NS antibodies to discriminate between vaccinated animals and those that have been infected. Australian Animal Health Laboratory, with the support of International Atomic Energy Agency, has developed an in-house FMD NS 3ABC c-ELISA (Morrissy et al., 2007) . It uses baculovirus expressed 3ABC antigen and a competing antibody, which is produced in chicken. This ELISA has been used and validated in Asia (IAEA, 2007) . There are a number of commercial ELISA kits available including the baculovirus 3ABC expressed antigen from CEDI Diagnostics, the E. coli 3ABC expressed antigen from Bommeli and the synthetic 3B antigen from UBI (de Bronsvoort et al., 2004) . There are possibilities of others at different stages of development and in-house ELISAs are also available in some laboratories. The CEDI diagnostics kit and the AAHL kit are both competitive ELISAs that can be used for all species, whereas the other kits are indirect ELISAs with separate kits for ruminants and pigs. The CEDI diagnostics kit has been found to be the most sensitive and specific ( B r o c c h i e t a l . , 2 0 0 6 ) . H o w e v e r, comparisons between the kits from CEDI and AAHL have shown that both ELISAs have similar performance characteristics.
QUALITY ASSURANCE AND QUALITY CONTROL "Quality is fitness for the intended purpose: Quality assurance is a system designed to assure test facility management of compliance with a quality standard, e.g. AS ISO 17025-2005" General requirements for use of ELISA (Morrissy et al., 2008) . The FMD LP-ELISA can detect antibodies against all seven FMD serotypes using polyclonal rabbit and guinea pig IgG antibodies to detect residual FMD antigen following invitro incubation of test serum and FMD antigen (the "liquid phase"). Result from the FMD LP-ELISA indicated high degree of correlation with VNT results for post infection and vaccinated animals, and it was suggested to be a suitable alternative to the VNT. It was also suggested that the FMD LP-ELISA could be used to estimate in-vitro protection to FMD challenge (Hamblin et al, 1986a (Hamblin et al, , 1986b (Hamblin et al, , 1987 .
The FMD LP-ELISA is one of the recommended ELISA methods for the detection of FMD antibodies (OIE, 2008) and is the primary test for determining vaccine titres, as it is being used in some laboratories. Recently, the FMD competitive (C)-ELISA has been developed for all seven serotypes of FMD in response to the issue of FMD LP-ELISA being less conducive to a large scale testing and automation. The FMD c-ELISA was developed using the same reagents as the FMD LP-ELISA, but without the "liquid phase" step, allowing a result in the same day (4-5 hours). The FMD c-ELISA was found to be more robust, sensitive and specific than the FMD LP-ELISA, and was used in the recent UK FMD outbreak to allow rapid screening of serum samples for FMD antibodies (Morrissy et al., 2008) .
FMD non-structural protein assays
Viral replication in FMD infected animals induces an immune response against the non-structural (NS) protein of the FMD. The response against NS protein is not serotype specific and indicates infection with any of the seven serotypes. Animals which are not infected with FMD but vaccinated normally do not develop a detectable antibody response against NS protein in the ELISA. Nevertheless, repeatedly applied, low quality vaccines, (e.g. lack of viral should cover at least the critical range of test results to be expected, e.g. strong positive control (C++); weak positive control, which is slightly above the cut-off (C+); and negative control. Analysis of internal quality control will give information about intraand inter-assay variations, intra-and interoperator variation, day to day variation etc. Critical parameters are basic statistics such as mean values, standard deviation, coefficient of variation, range and upper and lower control limits. Results can be charted and recorded as Levey-Jennings charts. This approach helps to identify trends in assay performance and is useful to prompt preventive corrective actions or trouble shooting. Internal quality control data can also be useful to access measurement of uncertainty, e.g. continued measurement of replicates of internal positive control close to the cut-off (De Clercq et al., 2008 ).
External quality assurance or proficiency testing measures the reproducibility of a test a n d i t s p e r f o r m a n c e i n d i f f e r e n t laboratories. It helps to standardize test results for the same test in different laboratories (inter-laboratory comparison, ring test or external quality assurance) or to harmonize test results from different tests in different laboratories (proficiency test round). Successful and regular participation approximately twice a year in external quality assurance programmes is an essential component of ISO 17025-2005 or OIE quality standard requirements, and therefore a pre-condition for accreditation (De Clercq et al., 2008) .
Equipment calibration and maintenance is another important part of quality assurance because it helps to ensure that tests are giving correct results. It is important that laboratories have a budget to allow them to maintain and calibrate their equipment. In summary, quality assurance and quality control are crucial elements in a laboratory's quality system and need to be well the competence of testing and calibration laboratories. Quality control is the technical realization of the quality assurance concept, e.g. calibration, assay validation, precision and accuracy of test results. Quality assurance and quality control principles are crucial requirements to comply with quality standards such as ISO 17025-2005 or the OIE's "Quality Standard and guidelines for Veterinary laboratories: Infectious disease" (De Clercq et al., 2008) .
The key components of quality assurance with regards to FMD diagnosis are:
Paper work/documentation of all tests into standard protocols. Validation data for diagnostic tests being used in the laboratory. Staff training and accreditation. Internal quality control (IQC) -positive and negative controls included in each test run. Analysis and charting to document results from IQC controls used in each test. External quality assurance -successful participation in proficiency test rounds. Documentation on all sample collection, storage and transport from the field, and storage and handling in the laboratory. C a l i b r a t i o n o f e q u i p m e n t a n d calibration records. Laboratory accreditation to a standard e.g. ISO 17025-2005. Quality control of the FMD diagnostic tests is achieved through a combination of internal quality control and external quality assurance. Repeatability and reproducibility are measurements of precision and results are of particular value to monitor the validity of test results (De Clercq et al., 2008) .
Internal quality control is useful to measure the repeatability of test results in a laboratory. Ideally, internal controls should be included as replicates in each test run and countries or at the district level.
For FMD serology the LP-ELISA is the test of choice in a country where FMD is endemic, as it is still the only test validated for post vaccination testing. The c-ELISA is used in FMD-free countries, and can be used to screen sera first as it has greater sensitivity, specificity and allows greater throughput. The NS-ELISA is used with the structural LP-ELISA or the c-ELISA to distinguish infected animals from vaccinated. The NS-ELISA does not identify carrier animals, but rather animals that have been infected with FMDV in the past. The NS-ELISA can be used to indicate disease prevalence or when a country is declaring freedom from FMD or in animal trading to indicate that animals have not been exposed to FMDV. The AC-ELISA is used for detection of FMD antigen and is the only test able to rapidly determine the serotype of an FMD outbreak. PCR is important as a confirmation for FMD genome and in further characterization of FMDV by sequencing. Virus isolation is important in producing high-titred stocks of FMDV for characterization or for growth of samples with low virus titre. Virus isolation is used in national or reference laboratories due to the high cost of maintaining tissue culture.
Overall, the quality of samples submitted to the laboratory is of utmost importance in achieving precise and accurate results and it involves: maintaining a cold chain, collection of appropriate samples for diagnosis, and collection in the appropriate sample collection buffer (i.e. phosphate/-glycerol for virus isolation and ELISA).
established to achieve accreditation to internationally accepted standards.
CONCLUSION
Effective diagnosis and control of livestock diseases requires a strong animal health network where laboratory staff, field veterinarians and epidemiologists work together. Laboratories contributing to the diagnostic network must be able to carry out diagnosis with OIE recommended or alternative tests within a recognized quality a s s u r a n c e s y s t e m . O I E r e f e r e n c e laboratories play important roles in monitoring disease situation in a country and ensuring that continued, updated and accurate information is forwarded to OIE. This is especially important with TADs, zoonotic, and new and emerging diseases because of their global threat.
The laboratory network in a country is made up of laboratories at different levels of standard and capability, from the national laboratory down to the province and district levels. The diagnostic tests used in these laboratories will differ according to their respective capabilities.
The national laboratory may have the full range of diagnostic tests, which includes virus isolation and a molecular capability for PCR and sequencing, whereas a provincial or district laboratory will most probably have low-cost technology. 
